The Effect of Digital Breast Tomosynthesis in Breast Cancer Long-term Survival: a Single Institution Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05600257

Enrollment

1517

Registered

2022-10-31

Start date

2011-09-01

Completion date

2021-08-31

Last updated

2022-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer

Brief summary

To investigate whether digital breast tomosynthesis (DBT) benefits survival improvement.

Detailed description

To suggest DBT for specific populations, compare the overall survival rate of women with digital mammography (DM) to the DBT screening for women with particular characteristics.

Interventions

DEVICEDBT

Image with digital breast tomosynthesis

DEVICEDM

Image with digital mammography

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

23 Years to 89 Years

Healthy volunteers

Inclusion criteria

* individuals were diagnosed with breast cancer according to the International Disease Classification Criteria

Exclusion criteria

* no surgery or incomplete surgical pathology stage * complete remission after neoadjuvant chemotherapy * non-breast cancer death * bilateral breast cancer * male breast cancer * no pre-surgery mammography image

Design outcomes

Primary

Measure	Time frame	Description
Overall survival rate	Up to 111 months	Compare the overall survival rate according to breast density type, cancer stage, mammography test type, and imaging modality.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026